Innovation in the treatment of Dissociative Identity Disorder: The application of schema therapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29102

Enrollment

Registered

2014-04-07

Start date

2014-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dissociative Identity Disorder

Interventions

Treatment will consist of two individual sessions a week during the first two years, followed by one individual session a week during the third year, with each session lasting 50 minutes. The treatmen

Farrell & Shaw, 2012), and adapted for the specific treatment needs of DID patients (Farrell & Shaw, 2013). Six monthly booster sessions will be included after the end of treatment.

Eligibility

Inclusion criteria

Inclusion criteria: 1) Main diagnosis of DID 2) Age between 18 and 60 3) Dutch literacy 4) Stable use of medication

Exclusion criteria

Exclusion criteria: 1) Mental retardation (IQ < 80) 2) Drug/alcohol dependency 3) Acute suïcide risk 4) Florid psychotic episodes

Design outcomes

Primary

Measure	Time frame
Dissociative symptoms (DSS), presence of DID (SCID-D), dropout	—

Secondary

Measure	Time frame
trait dissociative symptoms (MID), PTSD symptoms (PSS-SR), daily functioning (WHODAS), schema mode scores (SMI), treatment progress rated by therapist (PITQ), metamemory	—

Contacts

Public ContactR.J.C. Huntjens

Experimental Psychopathology, Department of Clinical Psychology University of Groningen Grote Kruisstraat 2/1

r.j.c.huntjens@rug.nl050-3636764

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)